Literature DB >> 3731418

Provocation of coronary spasm by dopamine in patients with active variant angina pectoris.

F Crea, S Chierchia, J C Kaski, G J Davies, A Margonato, D O Miran, A Maseri.   

Abstract

The effects of dopamine on arteries are different depending on the dose, route of administration, and receptor population. Its administration can cause vasodilation by stimulation of dopaminergic receptors, vasoconstriction by stimulation of alpha-adrenergic and serotonergic receptors, and even spasm of cerebral arteries when given intracisternally in dogs. The ability of dopamine to provoke coronary spasm was assessed in 18 patients with active vasospastic angina in whom this amine was infused at rates of 5, 10, and 15 micrograms/kg/min for periods of 5 min each. The 12-lead electrocardiogram and blood pressure (cuff) were monitored throughout the whole test. In nine patients dopamine caused angina and ischemic electrocardiographic changes suggestive of coronary spasm: ST segment elevation in six patients and ST segment depression in the absence of important coronary stenoses in the remaining three. Infusion of dopamine was repeated during coronary angiography in three patients with positive test results: this provoked occlusive coronary spasm with ST segment elevation in two patients and nonocclusive spasm with ST segment depression in the remainder. In conclusion, infusion of dopamine provokes coronary spasm in a sizeable proportion of patients with active vasospastic angina. Its administration may be detrimental in patients susceptible to coronary spasm, such as those with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731418     DOI: 10.1161/01.cir.74.2.262

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Coronary Artery Spasm.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

2.  Silent transmural myocardial ischemia during septic shock in a patient with normal coronary arteries.

Authors:  J Ortega-Carnicer; L Porras; R Alcázar; D Sánchez de la Nieta
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

3.  Pharmacology of the coronary circulation.

Authors:  J C Sill
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 4.  Provocative testing for coronary reactivity and spasm.

Authors:  Melody Zaya; Puja K Mehta; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2013-11-06       Impact factor: 24.094

5.  Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm.

Authors:  Takahiko Kinjo; Makoto Tanaka; Tomohiro Osanai; Shuji Shibutani; Ikuyo Narita; Tomohiro Tanno; Kimitaka Nishizaki; Hiroaki Ichikawa; Yoshihiro Kimura; Yuji Ishida; Takashi Yokota; Michiko Shimada; Yoshimi Homma; Hirofumi Tomita; Ken Okumura
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

Review 6.  Coronary artery spasm: Current knowledge and residual uncertainties.

Authors:  Massimo Slavich; Riyaz Suleman Patel
Journal:  Int J Cardiol Heart Vasc       Date:  2016-01-23

Review 7.  Coronary Vasospastic Angina: A Review of the Pathogenesis, Diagnosis, and Management.

Authors:  Rajan Rehan; James Weaver; Andy Yong
Journal:  Life (Basel)       Date:  2022-07-27

Review 8.  MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.

Authors:  Lucas Lentini Herling de Oliveira; Vinícius Machado Correia; Pedro Felipe Gomes Nicz; Paulo Rogério Soares; Thiago Luis Scudeler
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.